Ceftibuten dihydrate CAS:118081-34-8
Ceftibuten dihydrate is commonly prescribed by healthcare providers for the treatment of respiratory tract infections, urinary tract infections, otitis media, sinusitis, pharyngitis, tonsillitis, and other susceptible bacterial infections. Patients should consult with a healthcare professional to determine the appropriate dosage and duration of ceftibuten dihydrate treatment based on the specific type and severity of the infection. Patients typically take ceftibuten dihydrate orally as directed by their healthcare provider. It is important to complete the full course of treatment even if symptoms improve before completion to ensure the effective clearance of the bacterial infection and prevent relapse. While generally well-tolerated, common side effects of ceftibuten dihydrate may include gastrointestinal disturbances, headache, or allergic reactions. Patients should be monitored for any adverse reactions during treatment, and any severe or persistent side effects should be promptly reported to a healthcare provider for evaluation and management. Ceftibuten dihydrate is an effective oral antibiotic option when used appropriately under medical guidance for the treatment of bacterial infections.
Composition | C15H16N4O7S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 118081-34-8 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |